St George Street Capital, a charitable foundation based in England and Wales, has filed an Amendment No. 1 to the initial Statement on Schedule 13G, indicating that as of September 3, 2024, they no longer beneficially own more than 5% of Conduit Pharmaceuticals Inc.'s common stock. The amendment, dated November 6, 2024, confirms that St George Street Capital holds 0% interest in the company, with no voting or dispositive power over any shares. This filing follows the initial Schedule 13G filed on September 29, 2023. Conduit Pharmaceuticals, formerly known as Murphy Canyon Acquisition Corp., is headquartered in San Diego, California. The filing ensures compliance with SEC regulations and clarifies the ownership status of St George Street Capital with respect to Conduit Pharmaceuticals.

St George Street Capital, a charitable foundation based in England and Wales, has filed an Amendment No. 1 to the initial Statement on Schedule 13G, indicating that as of September 3, 2024, they no longer beneficially own more than 5% of Conduit Pharmaceuticals Inc.'s common stock. The amendment, dated November 6, 2024, confirms that St George Street Capital holds 0% interest in the company, with no voting or dispositive power over any shares. This filing follows the initial Schedule 13G filed on September 29, 2023. Conduit Pharmaceuticals, formerly known as Murphy Canyon Acquisition Corp., is headquartered in San Diego, California. The filing ensures compliance with SEC regulations and clarifies the ownership status of St George Street Capital with respect to Conduit Pharmaceuticals.